| 摘要 |
This invention relates to novel triazolyl hydrazide derivatives and a process for the preparation thereof. The new triazolyl hydrazide derivatives of the general formula (I), <CHEM> wherein Q represents hydrogen or a heterocyclic group optionally substituted by a C1-4 alkyl group; or a group of the formula SR<1>, wherein R<1> stands for C1-4 alkyl or phenyl-(C1-4 alkyl), or a group of the formula NR<2>R<3>, wherein R<2> and R<3> each represent hydrogen, straight or branched chained C1-6 alkyl or C2-6 alkenyl; Z represents hydrogen or a group of the formula (C=X)-(N-R<4>)-NR<5>R<6>, wherein X stands for oxygen or sulfur, R<4>, R<5> and R<6> each stand for hydrogen or C1-4 alkyl; R<7> denotes hydrogen, C1-4 alkyl or phenyl-(C1-4 alkyl) optionally substituted by one or more halogen atom(s), R<8> stands for hydrogen or a group of the formula -(C=X)-(N-R<4>)-NR<5>R<6>, wherein X, R<4>, R<5> and R<6> are as stated above, with the proviso that if Z represents a group of the formula -(C=X)-(N-R<5>)-NR<5>R<6>, R<8> stands for hydrogen, and if Z represents hydrogen, R<8> stands for a group of the formula (C=X)-(N-R<4>)-NR<5>R<6>, and pharmaceutically acceptable acid addition salts thereof exert valuable antianginal and/or gastric ulcer inhibiting properties and are useful in therapy. |
